Vena D - Search Results

1

Treatment of Anal High-Grade Squamous Intraepithelial Lesions to Prevent Anal Cancer.

Palefsky JM, Lee JY, Jay N, Goldstone SE, Darragh TM, Dunlevy HA, Rosa-Cunha I, Arons A, Pugliese JC, Vena D, Sparano JA, Wilkin TJ, Bucher G, Stier EA, Tirado Gomez M, Flowers L, Barroso LF, Mitsuyasu RT, Lensing SY, Logan J, Aboulafia DM, Schouten JT, de la Ossa J, Levine R, Korman JD, Hagensee M, Atkinson TM, Einstein MH, Cracchiolo BM, Wiley D, Ellsworth GB, Brickman C, Berry-Lawhorn JM; ANCHOR Investigators Group. Palefsky JM, et al. Among authors: vena d. N Engl J Med. 2022 Jun 16;386(24):2273-2282. doi: 10.1056/NEJMoa2201048. N Engl J Med. 2022. PMID: 35704479 Free PMC article. Clinical Trial.

2

gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma.

Schwartzentruber DJ, Lawson DH, Richards JM, Conry RM, Miller DM, Treisman J, Gailani F, Riley L, Conlon K, Pockaj B, Kendra KL, White RL, Gonzalez R, Kuzel TM, Curti B, Leming PD, Whitman ED, Balkissoon J, Reintgen DS, Kaufman H, Marincola FM, Merino MJ, Rosenberg SA, Choyke P, Vena D, Hwu P. Schwartzentruber DJ, et al. Among authors: vena d. N Engl J Med. 2011 Jun 2;364(22):2119-27. doi: 10.1056/NEJMoa1012863. N Engl J Med. 2011. PMID: 21631324 Free PMC article. Clinical Trial.

3

Phase II multicenter trial of bevacizumab plus fluorouracil and leucovorin in patients with advanced refractory colorectal cancer: an NCI Treatment Referral Center Trial TRC-0301.

Chen HX, Mooney M, Boron M, Vena D, Mosby K, Grochow L, Jaffe C, Rubinstein L, Zwiebel J, Kaplan RS. Chen HX, et al. Among authors: vena d. J Clin Oncol. 2006 Jul 20;24(21):3354-60. doi: 10.1200/JCO.2005.05.1573. J Clin Oncol. 2006. PMID: 16849749 Clinical Trial.

4

Treatment of hairy cell leukemia with 2-chlorodeoxyadenosine via the Group C protocol mechanism of the National Cancer Institute: a report of 979 patients.

Cheson BD, Sorensen JM, Vena DA, Montello MJ, Barrett JA, Damasio E, Tallman M, Annino L, Connors J, Coiffier B, Lauria F. Cheson BD, et al. Among authors: vena da. J Clin Oncol. 1998 Sep;16(9):3007-15. doi: 10.1200/JCO.1998.16.9.3007. J Clin Oncol. 1998. PMID: 9738569 Clinical Trial.

5

Preoperative and postoperative combination chemotherapy for potentially resectable gastric carcinoma.

Ajani JA, Mayer RJ, Ota DM, Steele GD, Evans D, Roh M, Sugarbaker DJ, Dumas P, Gray C, Vena DA, et al. Ajani JA, et al. Among authors: vena da. J Natl Cancer Inst. 1993 Nov 17;85(22):1839-44. doi: 10.1093/jnci/85.22.1839. J Natl Cancer Inst. 1993. PMID: 8230264

6

Paclitaxel for platinum-refractory ovarian cancer: results from the first 1,000 patients registered to National Cancer Institute Treatment Referral Center 9103.

Trimble EL, Adams JD, Vena D, Hawkins MJ, Friedman MA, Fisherman JS, Christian MC, Canetta R, Onetto N, Hayn R, et al. Trimble EL, et al. Among authors: vena d. J Clin Oncol. 1993 Dec;11(12):2405-10. doi: 10.1200/JCO.1993.11.12.2405. J Clin Oncol. 1993. PMID: 7902426 Clinical Trial.

7

Treatment of refractory chronic lymphocytic leukemia with fludarabine phosphate via the group C protocol mechanism of the National Cancer Institute: five-year follow-up report.

Sorensen JM, Vena DA, Fallavollita A, Chun HG, Cheson BD. Sorensen JM, et al. Among authors: vena da. J Clin Oncol. 1997 Feb;15(2):458-65. doi: 10.1200/JCO.1997.15.2.458. J Clin Oncol. 1997. PMID: 9053466 Clinical Trial.

8

Paclitaxel activity in heavily pretreated breast cancer: a National Cancer Institute Treatment Referral Center trial.

Abrams JS, Vena DA, Baltz J, Adams J, Montello M, Christian M, Onetto N, Desmond-Hellmann S, Canetta R, Friedman MA, et al. Abrams JS, et al. Among authors: vena da. J Clin Oncol. 1995 Aug;13(8):2056-65. doi: 10.1200/JCO.1995.13.8.2056. J Clin Oncol. 1995. PMID: 7543562 Clinical Trial.

9

Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.

Smith MA, Rubinstein L, Anderson JR, Arthur D, Catalano PJ, Freidlin B, Heyn R, Khayat A, Krailo M, Land VJ, Miser J, Shuster J, Vena D. Smith MA, et al. Among authors: vena d. J Clin Oncol. 1999 Feb;17(2):569-77. doi: 10.1200/JCO.1999.17.2.569. J Clin Oncol. 1999. PMID: 10080601

10

Tumor lysis syndrome: an uncommon complication of fludarabine therapy of chronic lymphocytic leukemia.

Cheson BD, Frame JN, Vena D, Quashu N, Sorensen JM. Cheson BD, et al. Among authors: vena d. J Clin Oncol. 1998 Jul;16(7):2313-20. doi: 10.1200/JCO.1998.16.7.2313. J Clin Oncol. 1998. PMID: 9667245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

86 results

Search Page